Vytorin/Zetia Settlement
Settlement Information Website

If You Paid Some or All of the Purchase Price
For Vytorin® and/or Zetia®
From November 1, 2002 through September 17, 2009,
You May Be Able To Get Money Back

**Update: Per the order signed February 9, 2010, the terms of the settlement have been approved.
Click here to view the final approval order.**

There is a Class Action Settlement with Merck & Co., Inc., Schering-Plough Corporation, Merck/Schering-Plough Pharmaceuticals, and certain other related entities (the “defendants”) concerning the prescription drugs Vytorin® and Zetia®. The name of the lawsuit is In re Vytorin/Zetia Marketing, Sales Practices and Products Liability Litigation, Master Docket No. 08-0285(DMC), pending in the United States District Court for the District of New Jersey.

This lawsuit claims that Vytorin® and Zetia® were marketed as being more effective than other anti-cholesterol drugs, and were sold at higher prices when they were no more effective than less expensive anti-cholesterol drugs. The defendants deny any wrongdoing and are settling this lawsuit to avoid the costs and expenses of further litigation.


Consumer Class


If you are a Consumer and you paid (or are obligated to pay) for Vytorin® and Zetia® from November 1, 2002 through September 17, 2009, please click here to read detailed information.


Third-Party Payor ("TPP") Class


If you are a Third-Party Payor (TPP) who reimbursed or paid for Vytorin® and Zetia® from November 1, 2002 through September 17, 2009, please click here to read detailed information.